Richard-Devantoy S

McGill Group for Suicide Studies, McGill University & Douglas Mental Health Research Institute, Montreal, Québec, Canada.

4 papers · ORCID

ArticleKetamine

The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial.

McAnulty C, Lavoie P, Cyr S +10

Europe PMC2026
ArticleKetamine

The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression.

Greenway KT, Garel N, Dinh-Williams LL +9

Europe PMC2026
ArticleKetamine

The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.

Garel N, Drury J, Thibault Lévesque J +9

Europe PMC2023
ArticleKetamine

Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings.

Garel N, Thibault Lévesque J, Sandra DA +5

Europe PMC2023